MYC and prostate adenocarcinoma: Invasive prostatic adenocarcinomas were observed in Ad.vec-treated 6-month old Hi-myc mice, whereas the invasive prostatic adenocarcinomas displayed decreased size in the Ad.tCCN1-CTV-m7-treated group and were barely detectable in the combination-treated groups.